Bausch Health Expands YUN Skincare Collaboration to Mexico and EMEA Markets
Event summary
- Bausch Health and YUN are expanding their strategic collaboration to Mexico and additional EMEA markets, including the Czech Republic, Slovakia, Ukraine, Bulgaria, and Kazakhstan.
- The expansion follows the 2025 launch of YUN's skincare solutions in Poland and includes both portfolio and geographic growth.
- YUN's probiotherapeutical skincare solutions for acne- and eczema-prone skin are being introduced in the new markets.
- The rollout in Kazakhstan is expected to continue in October 2026.
The big picture
Bausch Health's expansion of its collaboration with YUN underscores the growing importance of microbiome science in dermatology. The move aligns with broader industry trends towards science-led, natural skincare solutions. By leveraging YUN's proprietary YUN Probiotherapy™ technology platform, Bausch Health aims to strengthen its presence in strategically important markets. The collaboration reflects a strategic shift towards differentiated, science-based healthcare and skincare solutions.
What we're watching
- Market Penetration
- How effectively Bausch Health and YUN can penetrate the new markets with their microbiome-friendly skincare solutions.
- Regulatory Compliance
- Whether the expansion into Ukraine and Kazakhstan will face any regulatory hurdles.
- Revenue Growth
- The pace at which the expanded collaboration will contribute to Bausch Health's revenue growth.
Related topics